Skip to main content

Table 1 Clinical characteristics of patients

From: LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer

Clinical characteristics

All(188)

Age

51.87 ± 11.45

FIGO stage

 I-II

55 (29.26%)

 III-IV

133 (70.74%)

Grade

 3

156 (82.98%)

 2

18 (9.57%)

 1

14 (7.45%)

 Missing

0

Histology types

 Serous

125 (66.49%)

 Mucinous

13 (6.91%)

 Others

50 (26.60%)

surgical debulking

 Optimal

148 (78.72%)

 Suboptimal

40 (21.28%)

 Missing

0

Chemotherapy outcome

 chemosensitive

124 (65.96%)

 chemoresistant

64 (34.04%)